BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cherukuri A, Salama AD, Mehta R, Mohib K, Zheng L, Magee C, Harber M, Stauss H, Baker RJ, Tevar A, Landsittel D, Lakkis FG, Hariharan S, Rothstein DM. Transitional B cell cytokines predict renal allograft outcomes. Sci Transl Med 2021;13:eabe4929. [PMID: 33627487 DOI: 10.1126/scitranslmed.abe4929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Glass MC, Glass DR, Oliveria JP, Mbiribindi B, Esquivel CO, Krams SM, Bendall SC, Martinez OM. Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets. Cell Rep 2022;39:110728. [PMID: 35443184 DOI: 10.1016/j.celrep.2022.110728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Muir L, Jaffer A, Rees-Spear C, Gopalan V, Chang FY, Fernando R, Vaitkute G, Roustan C, Rosa A, Earl C, Rajakaruna GK, Cherepanov P, Salama A, McCoy LE, Motallebzadeh R. Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection. Kidney Int Rep 2021;6:1799-809. [PMID: 33942026 DOI: 10.1016/j.ekir.2021.03.902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Shankar S, Stolp J, Juvet SC, Beckett J, Macklin PS, Issa F, Hester J, Wood KJ. Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis. Nat Commun 2022;13:3121. [PMID: 35660734 DOI: 10.1038/s41467-022-30613-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Habal MV. Current Desensitization Strategies in Heart Transplantation. Front Immunol 2021;12:702186. [PMID: 34504489 DOI: 10.3389/fimmu.2021.702186] [Reference Citation Analysis]
5 Bottomley MJ, Brook MO, Shankar S, Hester J, Issa F. Towards regulatory cellular therapies in solid organ transplantation. Trends Immunol 2022;43:8-21. [PMID: 34844848 DOI: 10.1016/j.it.2021.11.001] [Reference Citation Analysis]
6 Chong AS, Sage PT, Alegre ML. Regulation of Alloantibody Responses. Front Cell Dev Biol 2021;9:706171. [PMID: 34307385 DOI: 10.3389/fcell.2021.706171] [Reference Citation Analysis]
7 Brinas F, Danger R, Brouard S. TCL1A, B Cell Regulation and Tolerance in Renal Transplantation. Cells 2021;10:1367. [PMID: 34206047 DOI: 10.3390/cells10061367] [Reference Citation Analysis]
8 Louis K, Fadakar P, Macedo C, Yamada M, Lucas M, Gu X, Zeevi A, Randhawa P, Lefaucheur C, Metes D. Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation. Kidney International 2022. [DOI: 10.1016/j.kint.2021.12.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ma X, Dai Y, Witzke O, Xu S, Lindemann M, Kribben A, Dolff S, Wilde B. Chloroquine Suppresses Effector B-Cell Functions and Has Differential Impact on Regulatory B-Cell Subsets. Front Immunol 2022;13:818704. [PMID: 35211119 DOI: 10.3389/fimmu.2022.818704] [Reference Citation Analysis]
10 Callemeyn J, Lamarthée B, Koenig A, Koshy P, Thaunat O, Naesens M. Allorecognition and the spectrum of kidney transplant rejection. Kidney Int 2021:S0085-2538(21)01143-1. [PMID: 34915041 DOI: 10.1016/j.kint.2021.11.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
11 Rushakoff JA, Gragert L, Pando MJ, Stewart D, Huang E, Kim I, Jordan S, Lindblad K, Zhang X, Lalli P, Patel JK, Kobashigawa JA, Kransdorf EP. HLA Homozygosity and Likelihood of Sensitization in Kidney Transplant Candidates. Transplantation Direct 2022;8:e1312. [DOI: 10.1097/txd.0000000000001312] [Reference Citation Analysis]